• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[勘误] CCR7通过丝裂原活化蛋白激酶调控头颈部转移性鳞状细胞癌中的细胞迁移和侵袭。

[Corrigendum] CCR7 regulates cell migration and invasion through MAPKs in metastatic squamous cell carcinoma of head and neck.

作者信息

Liu Fa-Yu, Safdar Jawad, Li Zhen-Ning, Fang Qi-Gen, Zhang Xu, Xu Zhong-Fei, Sun Chang-Fu

机构信息

Departments of Oromaxillofacial ‑ Head and Neck Surgery and Oral and Maxillofacial Surgery, School of Stomatology, China Medical University, Shenyang, Liaoning 110002, P.R. China.

出版信息

Int J Oncol. 2025 Jul;67(1). doi: 10.3892/ijo.2025.5761. Epub 2025 Jun 13.

DOI:10.3892/ijo.2025.5761
PMID:40511538
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12221124/
Abstract

Following the publication of the above article, the authors drew to the Editor's attention that, for the fluorescence microscopy experiments shown in Fig. 7 on p. 2506, they had inadvertently included the same data to show the results for the 'Control' and 'CCL19 + CCR7 mAb' experiments for E‑cadherin (top row, first and third images from the left). The Editorial Office subsequently conducted an independent assessment of the data in this paper and, regarding the scratch‑wound assay experiments shown in Fig. 5 also on p. 2506, two pairs of the images contained overlapping sections, such that data which were intended to show the results from differently performed experiments had apparently been derived from the same original sources.  Upon examining their original data, the authors have realized that Fig. 5 was also presented incorrectly, and the revised versions of Fig. 5, now containing the correct images for the 'CCL19+PD98059 0 h', 'CCL19+SP600125 0 h' and 'CCL19+SP600125 24 h' experiments, and of Fig. 7, now showing the correct data for the E‑cadherin 'Control' experiment, are shown on the next page. The authors wish to state that these errors did not affect the overall conclusions reported in the study. The authors are grateful to the Editor of for allowing them this opportunity to publish a Corrigendum, and all the authors agree with its publication. Furthermore, the authors apologize to the readership for any inconvenience caused. [International Journal of Oncology 45: 2502‑2510, 2014; DOI: 10.3892/ijo.2014.2674].

摘要

上述文章发表后,作者提请编辑注意,在第2506页图7所示的荧光显微镜实验中,他们无意中将相同的数据用于展示E-钙黏蛋白的“对照”和“CCL19 + CCR7单克隆抗体”实验结果(上排,从左起第一张和第三张图片)。编辑部随后对本文数据进行了独立评估,对于同样在第2506页图5所示的划痕实验,有两对图像包含重叠部分,以至于本应展示不同实验结果的数据显然来自相同的原始来源。在检查原始数据后,作者意识到图5也呈现错误,现在第2506页包含“CCL19 + PD98059 0小时”、“CCL19 + SP600125 0小时”和“CCL19 + SP600125 24小时”实验正确图像的图5修订版,以及展示E-钙黏蛋白“对照”实验正确数据的图7修订版见下一页。作者希望声明这些错误不影响该研究报告的总体结论。作者感谢《国际肿瘤学杂志》编辑给予他们发表勘误的机会,所有作者均同意发表此勘误。此外,作者就由此给读者带来的不便表示歉意。[《国际肿瘤学杂志》45: 2502 - 2510, 2014; DOI: 10.3892/ijo.2014.2674]

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bdc1/12221124/9a508de5fd2a/ijo-67-01-05761-g01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bdc1/12221124/c023aff69f25/ijo-67-01-05761-g00.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bdc1/12221124/9a508de5fd2a/ijo-67-01-05761-g01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bdc1/12221124/c023aff69f25/ijo-67-01-05761-g00.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bdc1/12221124/9a508de5fd2a/ijo-67-01-05761-g01.jpg

相似文献

1
[Corrigendum] CCR7 regulates cell migration and invasion through MAPKs in metastatic squamous cell carcinoma of head and neck.[勘误] CCR7通过丝裂原活化蛋白激酶调控头颈部转移性鳞状细胞癌中的细胞迁移和侵袭。
Int J Oncol. 2025 Jul;67(1). doi: 10.3892/ijo.2025.5761. Epub 2025 Jun 13.
2
[Corrigendum] Metastasis suppressor 1 expression in human ovarian cancer: The impact on cellular migration and metastasis.[勘误] 转移抑制因子1在人卵巢癌中的表达:对细胞迁移和转移的影响。
Int J Oncol. 2025 Aug;67(2). doi: 10.3892/ijo.2025.5770. Epub 2025 Jul 4.
3
[Corrigendum] Umbilical cord‑derived mesenchymal stem cells promote proliferation and migration in MCF‑7 and MDA‑MB‑231 breast cancer cells through activation of the ERK pathway.[勘误] 脐带间充质干细胞通过激活ERK通路促进MCF-7和MDA-MB-231乳腺癌细胞的增殖和迁移。
Oncol Rep. 2025 Sep;54(3). doi: 10.3892/or.2025.8933. Epub 2025 Jun 20.
4
[Corrigendum] The mechanism of adenosine‑mediated activation of lncRNA MEG3 and its antitumor effects in human hepatoma cells.[勘误] 腺苷介导的lncRNA MEG3激活机制及其在人肝癌细胞中的抗肿瘤作用
Int J Oncol. 2025 Jul;67(1). doi: 10.3892/ijo.2025.5765. Epub 2025 Jun 20.
5
[Corrigendum] Arctigenin inhibits triple-negative breast cancers by targeting CIP2A to reactivate protein phosphatase 2A.[勘误] 牛蒡子苷元通过靶向CIP2A重新激活蛋白磷酸酶2A来抑制三阴性乳腺癌。
Oncol Rep. 2025 Aug;54(2). doi: 10.3892/or.2025.8925. Epub 2025 Jun 6.
6
[Corrigendum] miR‑335 promotes ferroptosis by targeting ferritin heavy chain 1 in in vivo and in vitro models of Parkinson's disease.[勘误] 在帕金森病的体内和体外模型中,miR-335通过靶向铁蛋白重链1促进铁死亡。
Int J Mol Med. 2025 Aug;56(2). doi: 10.3892/ijmm.2025.5565. Epub 2025 Jun 13.
7
[Corrigendum] 2'‑Hydroxyflavanone inhibits epithelial‑mesenchymal transition, and cell migration and invasion via suppression of the Wnt/β‑catenin signaling pathway in prostate cancer.[勘误] 2'-羟基黄烷酮通过抑制前列腺癌中的Wnt/β-连环蛋白信号通路来抑制上皮-间质转化以及细胞迁移和侵袭。
Oncol Rep. 2025 Sep;54(3). doi: 10.3892/or.2025.8935. Epub 2025 Jun 27.
8
[Retracted] Intestinal trefoil factor activates the PI3K/Akt signaling pathway to protect gastric mucosal epithelium from damage.[已撤回] 肠三叶因子激活PI3K/Akt信号通路以保护胃黏膜上皮免受损伤。
Int J Oncol. 2025 Jul;67(1). doi: 10.3892/ijo.2025.5759. Epub 2025 Jun 6.
9
[Retracted] Fbxw7 regulates hepatocellular carcinoma migration and invasion via Notch1 signaling pathway.[已撤回]Fbxw7通过Notch1信号通路调控肝细胞癌的迁移和侵袭。
Int J Oncol. 2025 Jul;67(1). doi: 10.3892/ijo.2025.5763. Epub 2025 Jun 20.
10
[Corrigendum] Overexpression of IL‑9 induced by STAT3 phosphorylation is mediated by miR‑155 and miR‑21 in chronic lymphocytic leukemia.[勘误] 在慢性淋巴细胞白血病中,STAT3磷酸化诱导的IL-9过表达由miR-155和miR-21介导。
Oncol Rep. 2025 Sep;54(3). doi: 10.3892/or.2025.8940. Epub 2025 Jul 4.